Literature DB >> 2859415

Normal MPTP binding in parkinsonian substantial nigra: evidence for extraneuronal toxin conversion in human brain.

G R Uhl, J A Javitch, S H Snyder.   

Abstract

MPTP (N-methyl-4 phenyl-1,2,3,6 tetrahydropyridine) is a neurotoxin that induces a parkinsonian syndrome. 3H-MPTP binds densely to substantia nigra specimens from neurologically normal brains. It binds just as densely to specimens from patients with idiopathic parkinsonism despite substantial losses of dopaminergic neurons in this disorder. These results accord with findings in animal studies that suggest that MPTP binds to an extraneuronal enzyme, monoamine oxidase, which converts it to a toxic metabolite that is actively taken up and accumulates inside dopaminergic neurons. An MPTP-like toxin has been postulated to be a possible cause of idiopathic parkinsonism. Preventing uptake and concentration could be one means of blocking the action of such a toxin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859415     DOI: 10.1016/s0140-6736(85)91729-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.

Authors:  Y Du; Z Ma; S Lin; R C Dodel; F Gao; K R Bales; L C Triarhou; E Chernet; K W Perry; D L Nelson; S Luecke; L A Phebus; F P Bymaster; S M Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

2.  Dopamine transporters depolarize neurons by a channel mechanism.

Authors:  Lucia Carvelli; Paul W McDonald; Randy D Blakely; Louis J DeFelice
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-01       Impact factor: 11.205

3.  Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation.

Authors:  Minho Moon; Hyo Geun Kim; Lakkyong Hwang; Ji-Hyung Seo; Sehee Kim; Sunyoung Hwang; Soonyong Kim; Dahm Lee; Hyunju Chung; Myung Sook Oh; Kyung-Tae Lee; Seungjoon Park
Journal:  Neurotox Res       Date:  2009-03-17       Impact factor: 3.911

4.  Neuropathological study on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of the crab-eating monkey.

Authors:  J Tanaka; H Nakamura; S Honda; K Takada; S Kato
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 5.  Gene expression in the Parkinson's disease brain.

Authors:  Patrick A Lewis; Mark R Cookson
Journal:  Brain Res Bull       Date:  2011-12-03       Impact factor: 4.077

6.  TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF) Is Essential for MPTP-Induced Dopaminergic Neuroprotection via Microglial Cell M1/M2 Modulation.

Authors:  Minghui Shan; Sen Lin; Shurong Li; Yuchen Du; Haixia Zhao; Huarong Hong; Ming Yang; Xi Yang; Yongmei Wu; Liyi Ren; Jiali Peng; Jing Sun; Hongli Zhou; Bingyin Su
Journal:  Front Cell Neurosci       Date:  2017-02-22       Impact factor: 5.505

Review 7.  Revisiting the Role of Astrocytic MAOB in Parkinson's Disease.

Authors:  Min-Ho Nam; Moonsun Sa; Yeon Ha Ju; Mingu Gordon Park; C Justin Lee
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

8.  Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP+ by Transporter-Independent Export of the Intermediate MPDP+.

Authors:  Stefan Schildknecht; Regina Pape; Johannes Meiser; Christiaan Karreman; Tobias Strittmatter; Meike Odermatt; Erica Cirri; Anke Friemel; Markus Ringwald; Noemi Pasquarelli; Boris Ferger; Thomas Brunner; Andreas Marx; Heiko M Möller; Karsten Hiller; Marcel Leist
Journal:  Antioxid Redox Signal       Date:  2015-11-01       Impact factor: 8.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.